Study on I-DXd and Atezolizumab, With or Without Carboplatin, for First-Line Treatment of Extensive Stage Small Cell Lung Cancer | Clinical Trial

Study on I-DXd and Atezolizumab, With or Without Carboplatin, for First-Line Treatment of Extensive Stage Small Cell Lung Cancer | Clinical Trial | Right2Hope